Article Image
News Link • Education: Government Schools

FDA halts attention deficit disorder drug manufacture

• Associated Press
The FDA has withdrawn approval for a drug used to treat attention deficit hyperactivity disorder because it has been associated with liver problems, including death, but the FDA is allowing pharmacies to sell their remaining stock.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: